Stock Markets June 9, 2026 02:16 AM

JPMorgan Opens Coverage of GlobalData at Neutral, Says Recovery Intact but Execution Will Drive Further Gains

Broker sets a 135p target to December 2027 but urges proof that AI and operational investments deliver measurable commercial results

By Maya Rios
Share
Twitter Reddit Facebook LinkedIn

JPMorgan initiated coverage of GlobalData with a Neutral rating, assigning a December 2027 price target of 135 pence. The bank sees the company’s recovery narrative as intact but warns that further re-rating will require tangible evidence that investments in AI, sales capability and platform development translate into stronger top-line growth, improved retention and higher productivity.

JPMorgan Opens Coverage of GlobalData at Neutral, Says Recovery Intact but Execution Will Drive Further Gains
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • JPMorgan initiated coverage of GlobalData with a Neutral rating and a December 2027 price target of 135 pence, implying ~31% upside from a 103 pence close.
  • GlobalData shares have risen 43% since April, outperforming the FTSE 250 amid investor hopes for an earnings recovery in 2026.
  • JPMorgan says tangible proof that AI and operational investments boost retention, pricing power and productivity will be required for the stock to re-rate higher.

JPMorgan has begun formal coverage of GlobalData, the provider of data and analytics across multiple industries, assigning the stock a "Neutral" rating while underscoring that the firm's recovery story remains intact. The bank established a price target of 135 pence for December 2027, a level that implies roughly 31% upside versus the 103 pence closing price on Monday.

That valuation call comes after a significant run in the shares. GlobalData stock has climbed 43% since April, markedly outperforming the FTSE 250 index as market participants have grown more optimistic about a possible earnings rebound in 2026. JPMorgan cautioned, however, that much of the near-term multiple expansion has already occurred, and that further upside will be more contingent on execution than sentiment.

Evidence over expectation

In a research note led by Lara Simpson, the bank said investors are likely to demand direct proof that the company’s investments in artificial intelligence and wider operational transformation are translating into measurable commercial benefits. Specifically, JPMorgan highlighted the need for signs that AI initiatives are strengthening customer retention, enhancing pricing power and lifting productivity.

GlobalData runs a subscription-based intelligence platform that spans more than 20 industry verticals and serves in excess of 5,000 customers worldwide. The analysts noted that the underlying data products offer a point of differentiation and a defensive characteristic for the business. They argued that AI is likely to be most valuable when implemented as a layer that improves usability, workflow integration and productivity, rather than as a replacement for the fundamental information assets.

Operational hurdles and recent performance

JPMorgan took a cautious stance on how quickly growth will recover after a period in which GlobalData navigated acquisition integration, organisational restructuring and softer end-market demand. The bank pointed to company-level metrics showing underlying revenue growth slowed to 1% in 2025, while adjusted EBITDA margins declined to about 34% from 41% a year earlier. Management attributed the margin pressure in part to investments in sales capabilities, leadership hires and platform development.

The analysts said it will likely take several quarters of consistent delivery before investors are persuaded that recent spending is generating a sustainably higher growth trajectory. As a result, JPMorgan expects that future share-price performance will hinge less on market sentiment and more on demonstrable execution against the company’s strategic initiatives.

What JPMorgan sees next

According to the research note, the next meaningful upward move in the stock will be increasingly catalyst-dependent. The firm emphasised the need for clearer evidence of stronger top-line growth and more definitive proof that investments in AI are delivering commercial benefits if investors are to assign a higher valuation to the shares.


Note: The article reports JPMorgan's initiation and associated commentary as presented in the bank's research note, including the stated price target and the cited operating metrics for GlobalData.

Risks

  • Execution risk: Further gains depend on several quarters of consistent delivery showing that investments generate sustainable top-line growth - impacting the data and software sectors.
  • Integration and restructuring risk: Ongoing effects from prior acquisitions and organisational changes could continue to weigh on performance - relevant to corporate services and analytics providers.
  • End-market demand risk: Weaker demand conditions could limit revenue recovery and margin improvement, affecting technology and business intelligence markets.

More from Stock Markets

UK Watchdog Opens Probe Into PwC’s Audit of WH Smith for 2024 Year Jun 9, 2026 UK Stocks Retreat as Iran-Israel Truce Nears Completion, Helicopter Downing Adds Uncertainty Jun 9, 2026 Barclays Points to Three Forces Behind a European Value Upside Jun 9, 2026 AlzeCure Shares Spike After Eli Lilly Secures Global Rights to Alzstatin ACD680 Jun 9, 2026 Oxford Instruments posts modest revenue beat and robust order intake Jun 9, 2026